Clinical Trial Update: Leucine in Midlife Depression [Phase 2]

View source ↗

Summary

A Phase 2 trial from Emory University is evaluating leucine for midlife depression and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Leucine (Leucine)

Snippet

Sponsor: Emory University | Conditions: Major Depression | Phase 2 | Status: RECRUITING